Bank of Montreal’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.3M | Buy |
285,688
+271,076
| +1,855% | +$19.5M | 0.01% | 839 |
|
|
2026
Q1 | $963K | Buy |
14,612
+1,320
| +10% | +$83.9K | ﹤0.01% | 2055 |
|
|
2025
Q4 | $845K | Buy |
13,292
+160
| +1% | +$9.95K | ﹤0.01% | 2068 |
|
|
2025
Q3 | $722K | Sell |
13,132
-1,403
| -10% | -$57.8K | ﹤0.01% | 2107 |
|
|
2025
Q2 | $480K | Sell |
14,535
-1,266
| -8% | -$44K | ﹤0.01% | 2308 |
|
|
2025
Q1 | $635K | Buy |
15,801
+665
| +4% | +$30.6K | ﹤0.01% | 2046 |
|
|
2024
Q4 | $712K | Buy |
15,136
+1,285
| +9% | +$66.7K | ﹤0.01% | 2043 |
|
|
2024
Q3 | $725K | Buy |
13,851
+459
| +3% | +$25.6K | ﹤0.01% | 2196 |
|
|
2024
Q2 | $727K | Buy |
13,392
+1,727
| +15% | +$104K | ﹤0.01% | 2205 |
|
|
2024
Q1 | $823K | Sell |
11,665
-451
| -4% | -$34.9K | ﹤0.01% | 2117 |
|
|
2023
Q4 | $1.05M | Buy |
12,116
+911
| +8% | +$33K | ﹤0.01% | 2020 |
|
|
2023
Q3 | $403K | Sell |
11,205
-233,104
| -95% | -$7.76M | ﹤0.01% | 2595 |
|
|
2023
Q2 | $9.32M | Sell |
244,309
-131,510
| -35% | -$4.87M | ﹤0.01% | 1036 |
|
|
2023
Q1 | $13.5M | Buy |
375,819
+365,962
| +3,713% | +$14.9M | 0.01% | 820 |
|
|
2022
Q4 | $452K | Sell |
9,857
-483
| -5% | -$20.8K | ﹤0.01% | 2669 |
|
|
2022
Q3 | $556 | Buy |
10,340
+911
| +10% | +$43.8K | ﹤0.01% | 2521 |
|
|
2022
Q2 | $451 | Sell |
9,429
-15,282
| -62% | -$615K | ﹤0.01% | 2760 |
|
|
2022
Q1 | $940K | Buy |
24,711
+456
| +2% | +$16.2K | ﹤0.01% | 2391 |
|
|
2021
Q4 | $1.12M | Sell |
24,255
-5,253
| -18% | -$203K | ﹤0.01% | 1876 |
|
|
2021
Q3 | $1.01M | Buy |
29,508
+3,141
| +12% | +$92.5K | ﹤0.01% | 2488 |
|
|
2021
Q2 | $598K | Buy |
26,367
+5,003
| +23% | +$117K | ﹤0.01% | 2741 |
|
|
2021
Q1 | $518K | Buy |
21,364
+2,925
| +16% | +$62.5K | ﹤0.01% | 2615 |
|
|
2020
Q4 | $369K | Buy |
18,439
+12,425
| +207% | +$227K | ﹤0.01% | 2872 |
|
|
2020
Q3 | $171K | Sell |
6,014
-940
| -14% | -$22K | ﹤0.01% | 2805 |
|
|
2020
Q2 | $181K | Buy |
6,954
+5,730
| +468% | +$107K | ﹤0.01% | 2782 |
|
|
2020
Q1 | $14K | Sell |
1,224
-6,688
| -85% | -$85.3K | ﹤0.01% | 3371 |
|
|
2019
Q4 | $84K | Sell |
7,912
-292
| -4% | -$3K | ﹤0.01% | 3587 |
|
|
2019
Q3 | $94K | Buy |
8,204
+255
| +3% | +$3.2K | ﹤0.01% | 3332 |
|
|
2019
Q2 | $90K | Buy |
7,949
+4,628
| +139% | +$44.6K | ﹤0.01% | 3399 |
|
|
2019
Q1 | $27K | Buy |
3,321
+1,736
| +110% | +$12.8K | ﹤0.01% | 3560 |
|
|
2018
Q4 | $10K | Buy |
1,585
+331
| +26% | +$2.43K | ﹤0.01% | 3880 |
|
|
2018
Q3 | $12K | Sell |
1,254
-10
| -0.8% | -$80 | ﹤0.01% | 3867 |
|
|
2018
Q2 | $11K | Buy |
1,264
+327
| +35% | +$2.72K | ﹤0.01% | 3928 |
|
|
2018
Q1 | $7K | Hold |
937
| – | – | ﹤0.01% | 3854 |
|
|
2017
Q4 | $8K | Sell |
937
-95,437
| -99% | -$1.08M | ﹤0.01% | 3837 |
|
|
2017
Q3 | $1.4M | Buy |
96,374
+72,839
| +309% | +$995K | ﹤0.01% | 1805 |
|
|
2017
Q2 | $285K | Buy |
23,535
+11,527
| +96% | +$160K | ﹤0.01% | 2488 |
|
|
2017
Q1 | $154K | Sell |
12,008
-163
| -1% | -$1.91K | ﹤0.01% | 2607 |
|
|
2016
Q4 | $146K | Buy |
12,171
+2,098
| +21% | +$22.3K | ﹤0.01% | 2646 |
|
|
2016
Q3 | $93K | Sell |
10,073
-3,227
| -24% | -$33.7K | ﹤0.01% | 2813 |
|
|
2016
Q2 | $126K | Sell |
13,300
-3,357
| -20% | -$27.5K | ﹤0.01% | 2703 |
|
|
2016
Q1 | $117K | Hold |
16,657
| – | – | ﹤0.01% | 2727 |
|
|
2015
Q4 | $174K | Buy |
16,657
+3,636
| +28% | +$35.7K | ﹤0.01% | 2502 |
|
|
2015
Q3 | $87K | Buy |
+13,021
| New | +$88.9K | ﹤0.01% | 2692 |
|
|
2014
Q3 | – | Sell |
-29,790
| Closed | -$143K | – | 4087 |
|
|
2014
Q2 | $143K | Buy |
+29,790
| New | +$182K | ﹤0.01% | 2657 |
|
|
2013
Q4 | – | Sell |
-12,100
| Closed | -$92K | – | 3750 |
|
|
2013
Q3 | $92K | Buy |
+12,100
| New | +$130K | ﹤0.01% | 2540 |
|
Other funds holding CYTK
ACA
RI
PCH
Bank of Montreal's CYTK Position: Q2 2026 in Review
Bank of Montreal increased its Cytokinetics (CYTK) stake by 1,855% in Q2 2026, buying an estimated $19.5M and bringing the position to 285,688 shares worth $24.3M. The position accounts for 0.01% of the portfolio, ranked #839.
Bank of Montreal first reported a position in CYTK in Q3 2013 and has held it in 46 quarters since. 447 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- Bank of Montreal held 285,688 shares of Cytokinetics worth $24.3M as of Q2 2026.
- Bank of Montreal bought 271,076 Cytokinetics shares in Q2 2026, an estimated $19.5M.
- Cytokinetics made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #839 holding.
- Bank of Montreal first reported a position in Cytokinetics in Q3 2013 and has held it in 46 quarters since.
- 447 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.